Soiken Holdings Inc.
2385.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.75B
Close$
$260.58
18.4% upside
Current Fair Value
18.4% upsideUndervalued by 18.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.75 Billion |
|---|---|
| Enterprise Value | $875.69 Million |
| Dividend Yield | $10.00 (4.55%) |
| Earnings per Share | $8.12 |
| Beta | 0.12 |
| Outstanding Shares | 26,157,000 |
Return
| Return on Equity | 3.47% |
|---|---|
| Return on Assets | 3.10% |
| Return on Invested Capital | 4.00% |
Valuation & Multiples
| P/E Ratio | 27.09 |
|---|---|
| PEG | -57.95 |
| Price to Sales | 1.49 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | 0.23 |
| Enterprise Value to EBIT | 3.59 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Soiken Holdings Inc.
45 employees
CEO: Kentaro Ishigami Founded in 1994 and headquartered in Toyonaka, Japan, Soiken Holdings Inc. primarily focuses on the advancement of biomarkers. The company’s operations span a diverse range of health and wellness sectors. It is actively involved in the c...